-
Journal of Thoracic Oncology : Official... Sep 2015
Topics: Female; Humans; Lung Neoplasms; Male; World Health Organization
PubMed: 26291007
DOI: 10.1097/JTO.0000000000000663 -
Journal of Pain and Symptom Management Aug 2002
Review
Topics: Humans; International Cooperation; Palliative Care; World Health Organization
PubMed: 12231124
DOI: 10.1016/s0885-3924(02)00440-2 -
Leukemia Jul 2022
Topics: Humans; Neoplasms; World Health Organization
PubMed: 35732830
DOI: 10.1038/s41375-022-01625-x -
BMJ Global Health Apr 2021Much has been written about WHO. Relatively little is known, however, about the organisation's evolving relationship with health-related personal beliefs, 'faith-based...
Much has been written about WHO. Relatively little is known, however, about the organisation's evolving relationship with health-related personal beliefs, 'faith-based organisations' (FBOs), religious leaders and religious communities ('religious actors'). This article presents findings from a 4-year research project on the 'spiritual dimension' of health and WHO conducted at the University of Zürich. Drawing on archival research in Geneva and interviews with current and former WHO staff, consultants and programme partners, we identify three stages in this relationship. Although since its founding individuals within WHO occasionally engaged with religious actors, it was not until the 1970s, when the primary healthcare strategy was developed in consultation with the Christian Medical Commission, that their concerns began to influence WHO policies. By the early 1990s, the failure to roll out primary healthcare globally was accompanied by a loss of interest in religion within WHO. With the spread of HIV/AIDS however, health-related religious beliefs were increasingly recognised in the development of a major quality of life instrument by the Division of Mental Health, and the work of a WHO expert committee on cancer pain relief and the subsequent establishment of palliative care. While the 1990s saw a cooling off of activities, in the years since, the HIV/AIDS, Ebola and COVID-19 crises have periodically brought religious actors to the attention of the organisation. This study focusses on what we suggest may be understood as a trend towards a closer association between the activities of WHO and religious actors, which has occurred in fits and starts and is marked by attempts at institutional translation and periods of forgetting and remembering.
Topics: COVID-19; Faith-Based Organizations; Global Health; Humans; Interinstitutional Relations; World Health Organization
PubMed: 33888486
DOI: 10.1136/bmjgh-2020-004073 -
BMJ (Clinical Research Ed.) May 1997
Topics: Decision Making; Happiness; Health; Humans; World Health Organization
PubMed: 9161320
DOI: 10.1136/bmj.314.7091.1409 -
International Journal of Environmental... Jul 2022Good health and wellbeing while aging is an ambitious goal proposed by the World Health Organization (WHO) and a core value for most governments [...].
Good health and wellbeing while aging is an ambitious goal proposed by the World Health Organization (WHO) and a core value for most governments [...].
Topics: World Health Organization
PubMed: 35886683
DOI: 10.3390/ijerph19148835 -
Public Health Feb 2014This article takes a historical perspective on the changing position of WHO in the global health architecture over the past two decades. From the early 1990s a number of... (Review)
Review
This article takes a historical perspective on the changing position of WHO in the global health architecture over the past two decades. From the early 1990s a number of weaknesses within the structure and governance of the World Health Organization were becoming apparent, as a rapidly changing post Cold War world placed more complex demands on the international organizations generally, but significantly so in the field of global health. Towards the end of that decade and during the first half of the next, WHO revitalized and played a crucial role in setting global health priorities. However, over the past decade, the organization has to some extent been bypassed for funding, and it lost some of its authority and its ability to set a global health agenda. The reasons for this decline are complex and multifaceted. Some of the main factors include WHO's inability to reform its core structure, the growing influence of non-governmental actors, a lack of coherence in the positions, priorities and funding decisions between the health ministries and the ministries overseeing development assistance in several donor member states, and the lack of strong leadership of the organization.
Topics: Global Health; Health Priorities; History, 20th Century; History, 21st Century; International Cooperation; Leadership; World Health Organization
PubMed: 24388640
DOI: 10.1016/j.puhe.2013.08.008 -
Canadian Journal of Public Health =... Dec 2021
Topics: Humans; Malaria Vaccines; World Health Organization
PubMed: 34846704
DOI: 10.17269/s41997-021-00593-6 -
Head and Neck Pathology Mar 2017
Topics: Head and Neck Neoplasms; Humans; World Health Organization
PubMed: 28247234
DOI: 10.1007/s12105-017-0785-2 -
Annals of Medicine Dec 2022The global burden of hypertension remains an unsolved problem, especially in low- and middle-income countries (LMICs). For this reason, clinical practice guidelines... (Review)
Review
The global burden of hypertension remains an unsolved problem, especially in low- and middle-income countries (LMICs). For this reason, clinical practice guidelines containing the latest evidence-based recommendations are crucial in the management of hypertension. It is noteworthy that guidelines simply translated from those of high-income countries (HICs) are not the solution to the problem of hypertension in LMICs. Among the numerous guidelines available, those of the World Health Organisation and the International Society of Hypertension are the latest to be published as of the writing of this article. In this review, we conducted both general and specific comparisons between the recommendations supplied by both guidelines. Differences in aspects of hypertension management such as the timing of antihypertensive initiation, assessment of comorbidities and cardiovascular risk factors, pharmacological therapy selection, and blood pressure target and reassessment are explored. Lastly, the implications of the differences found between the two guidelines in both LMICs and HICs are discussed.Key messagesCurrently, with low treatment and control rates, hypertension remains a burden in low- and middle-income countries (LMICs).The lack of customised guidelines for LMICs cannot be solved simply by adopting guidelines from high-income countries.The World Health Organisation (WHO) recently published a clinical guideline for the pharmacological management of hypertension in LMICs. We compare select recommendations from the guidelines to those published by the International Society of Hypertension.
Topics: Antihypertensive Agents; Blood Pressure; Humans; Hypertension; Poverty; World Health Organization
PubMed: 35291891
DOI: 10.1080/07853890.2022.2044510